Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Alexander Hindenburg"'
Autor:
Cinnia Huang, Brett Slater, Robert Rudd, Nandakishore Parchuri, Rene Hull, Michelle Dupuis, Alexander Hindenburg
Publikováno v:
Emerging Infectious Diseases, Vol 8, Iss 12, Pp 1367-1371 (2002)
West Nile virus (WNV) was isolated from a patient who developed encephalitis while undergoing treatment with CHOP (cyclophosphamide, hydroxydoxorubicin, vincristine [Oncovin], predisone) and rituximab for a non-Hodgkin B-cell lymphoma. Both standard
Externí odkaz:
https://doaj.org/article/2104f436047742a0867e7dfca3b6ad85
Autor:
Alexander Hindenburg, Cinnia Huang
Publikováno v:
Emerging Infectious Diseases, Vol 9, Iss 5, Pp 608-609 (2003)
Externí odkaz:
https://doaj.org/article/ba5be87dacc84191a4b08ecbc4c248f5
Autor:
Douglas K Marks, Nibash Budhathoki, John Kucharczyk, Faisal Fa’ak, Nina D’Abreo, Maryann Kwa, Magdalena Plasilova, Shubhada Dhage, Phyu Phyu Soe, Daniel Becker, Alexander Hindenburg, Johanna Lee, Megan Winner, Chinyere Okpara, Alison Daly, Darshi Shah, Angela Ramdhanny, Marleen Meyers, Ruth Oratz, James Speyer, Yelena Novik, Freya Schnabel, Simon A Jones, Sylvia Adams
Publikováno v:
The Oncologist. 27:89-96
PurposeProvide real-world data regarding the risk for SARS-CoV-2 infection and mortality in breast cancer (BC) patients on active cancer treatment.MethodsClinical data were abstracted from the 3778 BC patients seen at a multisite cancer center in New
Autor:
Adam M. Brufsky, Midas Kuilman, Rita Mukhtar, Denise M. Wolf, Christina Yau, Joyce O’Shaughnessy, Cathy Graham, Vijayakrishna K. Gadi, Pat Whitworth, Alexander Hindenburg, Ian Grady, Gordon Srkalovic, Kent Hoskins, Ajay Dhakal, Cynthia Ma, Natasha Hunter, Jennifer Crozier, Blanche Mavromatis, Lorenza Mittempergher, Christine Finn, Shraddha Modh, Erin B. Yoder, Patricia Dauer, Andrea Menicucci, Bas van der Baan, William Audeh, Laura J. Esserman
Publikováno v:
Cancer Research. 83:PD9-08
BACKGROUND: Immune checkpoint inhibitors in combination with chemotherapy have demonstrated an improvement of pathologic complete response (pCR) in patients with HR-HER2- and MammaPrint (MP) High Risk, HR+HER2- tumors in the I-SPY2 TRIAL. However, no
Autor:
Alexander Hindenburg, Christopher M. Petrilli, Meng Cao, Leora I. Horwitz, Ronald Goldenberg, Dennis Kunichoff, Shadi Yaghi, Samrachana Adhikari, Sam Parnia, Emma Simon, Harmony R. Reynolds, Yindalon Aphinyanaphongs, James Horowitz, Jeffrey S. Berger, Nancy Amoroso, James Slater, Eugene Yuriditsky, Tania Ahuja, Judith S. Hochman
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology
Supplemental Digital Content is available in the text.
Objective: To determine the prevalence of D-dimer elevation in coronavirus disease 2019 (COVID-19) hospitalization, trajectory of D-dimer levels during hospitalization, and its association w
Objective: To determine the prevalence of D-dimer elevation in coronavirus disease 2019 (COVID-19) hospitalization, trajectory of D-dimer levels during hospitalization, and its association w
Publikováno v:
Blood. 136:12-13
Background: The clinical use of Direct oral anticoagulants (DOACs), as opposed to warfarin, has become more prevalent in patients with extremes in body weight. However, both the International Society on Thrombosis and Haemostasis' (ISTH) and anti-thr
Autor:
Amishi Desai, Joseph Mathew, Rose Calixte, Anish Desai, Steve H. Salzman, Alexander Hindenburg, Malaygiri Aparnath
Publikováno v:
Lung. 194:605-611
Recent studies have demonstrated non-inferiority of rivaroxaban when compared to warfarin for the treatment of pulmonary embolism and deep venous thrombosis. Analysis of data from the EINSTEIN trials has demonstrated that patients who received rivaro
Publikováno v:
Journal of thrombosis and thrombolysis. 46(4)
Despite advantages of low molecular weight heparin (LMWH), enoxaparin over heparin (UFH) for venous thromboembolism (VTE), a hospital’s prescribing trends analysis showed use of each was about equal. In an attempt to increase LMWH over UFH use, ele
Autor:
Josephine Pineda Dela Cruz, Kyle Nevins, Anusiyanthan Isaac Mariampillai, Alexander Hindenburg, Abirami Sivapiragasam, Jason Suh
Publikováno v:
Anticancer research. 37(7)
Background Cancer antigen CA72-4 is a tumor marker found to be elevated in a variety of human adenocarcinomas. Using the DRG TM-CA72-4, we quantified the elevation of CA72-4 compared to current United States Food And Drug Administration-approved tumo
Autor:
Anusiyanthan Isaac Mariampillai, Amishi Desai, Josephine Pineda Dela Cruz, Alexander Hindenburg, Jason Suh, Anish Desai
Publikováno v:
Journal of thrombosis and thrombolysis. 43(2)
Venous thromboembolism (VTE) remains the number one preventable cause of hospital acquired mortality and morbidity. Each year, more than 12 million patients are at risk for VTE. The delivery of appropriate and timely VTE prophylaxis is still suboptim